R. Wigand

669 total citations
32 papers, 474 citations indexed

About

R. Wigand is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, R. Wigand has authored 32 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 8 papers in Hematology and 5 papers in Immunology. Recurrent topics in R. Wigand's work include Spondyloarthritis Studies and Treatments (4 papers), Autoimmune and Inflammatory Disorders Research (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). R. Wigand is often cited by papers focused on Spondyloarthritis Studies and Treatments (4 papers), Autoimmune and Inflammatory Disorders Research (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). R. Wigand collaborates with scholars based in Germany, Austria and United States. R. Wigand's co-authors include Jürgen E. Scherberich, Wolfgang Andreas Nockher, W. Schoeppe, J. P. Kaltwasser, A. Falkenbach, Markus Hecker, Rudi Busse, J. Meyer, G. M. Oremek and A Bartha and has published in prestigious journals such as Annals of the Rheumatic Diseases, Clinica Chimica Acta and Human Genetics.

In The Last Decade

R. Wigand

26 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Wigand Germany 11 152 116 116 107 78 32 474
James J. Castles United States 19 223 1.5× 274 2.4× 74 0.6× 175 1.6× 54 0.7× 44 808
E Gugler Switzerland 13 98 0.6× 129 1.1× 178 1.5× 68 0.6× 121 1.6× 46 678
Thompson Js United States 11 112 0.7× 83 0.7× 73 0.6× 27 0.3× 38 0.5× 47 517
A E Gabrielsen United States 14 462 3.0× 91 0.8× 123 1.1× 96 0.9× 43 0.6× 28 737
F Hamerlinck Netherlands 13 185 1.2× 59 0.5× 34 0.3× 77 0.7× 67 0.9× 26 514
G. Wick Austria 14 327 2.2× 258 2.2× 61 0.5× 56 0.5× 32 0.4× 27 728
Michael Judo United States 7 396 2.6× 191 1.6× 125 1.1× 83 0.8× 57 0.7× 7 688
Michael D. Zanolli United States 14 329 2.2× 66 0.6× 48 0.4× 102 1.0× 57 0.7× 28 757
J F Mowbray United Kingdom 15 232 1.5× 105 0.9× 42 0.4× 29 0.3× 46 0.6× 36 529
M Schlesinger Israel 14 325 2.1× 167 1.4× 57 0.5× 24 0.2× 56 0.7× 32 674

Countries citing papers authored by R. Wigand

Since Specialization
Citations

This map shows the geographic impact of R. Wigand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Wigand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Wigand more than expected).

Fields of papers citing papers by R. Wigand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Wigand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Wigand. The network helps show where R. Wigand may publish in the future.

Co-authorship network of co-authors of R. Wigand

This figure shows the co-authorship network connecting the top 25 collaborators of R. Wigand. A scholar is included among the top collaborators of R. Wigand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Wigand. R. Wigand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ueberall, Michael A., Gerhard Mueller-Schwefe, R. Wigand, & Ute Essner. (2016). Efficacy, tolerability, and safety of an oral enzyme combination vs diclofenac in osteoarthritis of the knee: results of an individual patient-level pooled reanalysis of data from six randomized controlled trials. Journal of Pain Research. Volume 9. 941–961. 11 indexed citations
2.
Wigand, R., et al.. (2008). Morbus Still des Erwachsenen: Differentialdiagnose bei rekurrenter Pharyngitis, Fieber unklarer Genese und exzessiver Hyperferritinämie. DMW - Deutsche Medizinische Wochenschrift. 124(27). 829–832. 1 indexed citations
3.
Wigand, R., et al.. (2004). Celecoxib in der symptomatischen Therapie bei aktivierter Osteoarthrose oder rheumatoider Arthritis. DMW - Deutsche Medizinische Wochenschrift. 129(21). 1188–1192. 4 indexed citations
4.
Oremek, G. M., et al.. (2003). Pyruvate kinase type tumor M2 plasma levels in patients afflicted with rheumatic diseases.. PubMed. 23(2A). 1131–4. 18 indexed citations
5.
Witte, T, Matthias Tenbusch, H. H. Peter, et al.. (2000). IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.. PubMed. 27(11). 2617–20. 44 indexed citations
6.
Gottschalk, René, R. Wigand, Christoph F. Dietrich, et al.. (2000). Total iron-binding capacity and serum transferrin determination under the influence of several clinical conditions. Clinica Chimica Acta. 293(1-2). 127–138. 28 indexed citations
7.
Falkenbach, A., Manfred Herold, & R. Wigand. (2000). Interleukin-6 serum concentration in ankylosing spondylitis: a reliable predictor of disease progression in the subsequent year?. Rheumatology International. 19(4). 149–151. 10 indexed citations
8.
Falkenbach, A., et al.. (1999). Recreational exercises and mobility in young patients with ankylosing spondylitis (as). Sports medicine, training, and rehabilitation. 9(2). 101–106. 3 indexed citations
9.
Falkenbach, A., et al.. (1999). Analyse du programme autonome des exercices physiques pratiqués par les malades souffrant de pelvispondylite rhumatismale. Annales de Réadaptation et de Médecine Physique. 42(6). 306–310. 3 indexed citations
10.
Falkenbach, A., et al.. (1998). Pain in ankylosing spondylitis- the impact of the weather. International Journal of Environmental Health Research. 8(1). 85–89. 4 indexed citations
11.
Wigand, R., J. Meyer, Rudi Busse, & Markus Hecker. (1997). Increased serum NG-hydroxy-l-arginine in patients with rheumatoid arthritis and systemic lupus erythematosus as an index of an increased nitric oxide synthase activity. Annals of the Rheumatic Diseases. 56(5). 330–332. 42 indexed citations
12.
13.
14.
Falkenbach, A., et al.. (1997). [Specific and aspecific sports activities of patients with Bechterew's disease].. PubMed. 36(1). 48–50. 2 indexed citations
15.
Falkenbach, A., et al.. (1994). Polyserositis with adult Still's disease onset during pregnancy. Clinical Rheumatology. 13(3). 513–517. 14 indexed citations
16.
Falkenbach, A., et al.. (1993). Cyclosporin Treatment in Rheumatoid Arthritis is Associated with an Increased Serum Activity of β-Glucuronidase. Scandinavian Journal of Rheumatology. 22(2). 83–85. 12 indexed citations
17.
Kirschfink, Michael, et al.. (1993). Complete functional C1q deficiency associated with systemic lupus erythematosus (SLE). Clinical & Experimental Immunology. 94(2). 267–272. 31 indexed citations
18.
Weiland, Florian, Günther M. Keil, Matthias J. Reddehase, et al.. (1986). Subject Index, Vol. 26, 1986. Intervirology. 26(4). 235–236. 2 indexed citations
19.
Wigand, R.. (1976). Book review. 151(5). 466–467. 3 indexed citations
20.
Ananthakrishnan, Radha, William S. Beck, Henrik Walter, et al.. (1973). A mother-child combination analysis for AB0-Hp interaction. Human Genetics. 18(3). 203–206. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James J. Castles Breakdown of academic impact, for papers by E Gugler Breakdown of academic impact, for papers by Thompson Js Breakdown of academic impact, for papers by A E Gabrielsen Breakdown of academic impact, for papers by F Hamerlinck Breakdown of academic impact, for papers by G. Wick Breakdown of academic impact, for papers by Michael Judo Breakdown of academic impact, for papers by Michael D. Zanolli Breakdown of academic impact, for papers by J F Mowbray Breakdown of academic impact, for papers by M Schlesinger
Rankless by CCL
2026